BDRX logo

Biodexa Pharmaceuticals (BDRX) Operating Expenses

Annual Operating Expenses

$5.39 M
-$211.90 K-3.79%

31 December 2023

BDRX Operating Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BDRX Operating Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-3.8%-
3 y3 years-15.2%-
5 y5 years-8.1%-

BDRX Operating Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-15.2%+34.0%
5 y5 years-15.2%+34.0%
alltimeall time-36.1%+34.0%

Biodexa Pharmaceuticals Operating Expenses History

DateAnnualQuarterly
Dec 2023
$5.39 M(-3.8%)
-
Dec 2022
$5.60 M(+39.2%)
-
Dec 2021
$4.02 M(-36.7%)
-
Dec 2020
$6.35 M(+19.8%)
-
Dec 2019
$5.30 M(-9.6%)
-
DateAnnualQuarterly
Dec 2018
$5.86 M(+2.4%)
-
Dec 2017
$5.73 M(+30.3%)
-
Dec 2016
$4.40 M(-47.8%)
-
Dec 2015
$8.43 M(+16.0%)
-
Dec 2014
$7.26 M(+70.6%)
-
Dec 2013
$4.26 M
-

FAQ

  • What is Biodexa Pharmaceuticals annual total operating expenses?
  • What is the all time high annual operating expenses for Biodexa Pharmaceuticals?
  • What is Biodexa Pharmaceuticals annual operating expenses year-on-year change?

What is Biodexa Pharmaceuticals annual total operating expenses?

The current annual operating expenses of BDRX is $5.39 M

What is the all time high annual operating expenses for Biodexa Pharmaceuticals?

Biodexa Pharmaceuticals all-time high annual total operating expenses is $8.43 M

What is Biodexa Pharmaceuticals annual operating expenses year-on-year change?

Over the past year, BDRX annual total operating expenses has changed by -$211.90 K (-3.79%)